INOVIO Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate for COVID-19, to include Colombia following Regulatory Authorization

Media Type
Article
Publish or Event Date
Research Institution
INOVIO
Short Title
INOVIO Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate for COVID-19, to include Colombia following Regulatory Authorization
Content Coordinator
Content Manager

Few Variants Arise from Acute SARS-CoV-2 Infections

Community Engagement Ensures Equitable Inclusion in Vaccine Trials

Enesi Pharma Enters Agreement with National Institutes of Health to Evaluate ImplaVax®-enabled Flu Vaccines

Media Type
Article
Publish or Event Date
Research Institution
Enesi Pharma
Short Title
Enesi Pharma Enters Agreement with National Institutes of Health to Evaluate ImplaVax®-enabled Flu Vaccines
Content Coordinator
Content Manager

Preparing for Potential Pandemics is Focus of New Federal Grant to Penn State

Study Supports Safety of COVID-19 Vaccines in People with a History of Severe Allergic Reactions

Media Type
Article
Publish or Event Date
Research Institution
Massachusetts General Hospital
Short Title
Study Supports Safety of COVID-19 Vaccines in People with a History of Severe Allergic Reactions
Content Coordinator
Content Manager

Prompt Procurement and Roll-Out of COVID-19 Vaccines Are as Important as their Efficacy

Media Type
Article
Publish or Event Date
Research Institution
Massachusetts General Hospital
Short Title
Prompt Procurement and Roll-Out of COVID-19 Vaccines Are as Important as their Efficacy
Content Coordinator
Content Manager

Sequencing Respiratory Viruses Provides New Insight on Coinfections, Viral Spread and COVID

Media Type
Article
Publish or Event Date
Research Institution
Augusta University
Short Title
Sequencing Respiratory Viruses Provides New Insight on Coinfections, Viral Spread and COVID
Content Coordinator
Content Manager

Adaptive Phage Therapeutics Announces Strategic Agreement with ARLG to Support Phase 1b/2 Cystic Fibrosis Study

Media Type
Article
Publish or Event Date
Research Institution
Adaptive Phage Therapeutics
Short Title
Adaptive Phage Therapeutics Announces Strategic Agreement with ARLG to Support Phase 1b/2 Cystic Fibrosis Study
Content Coordinator
Content Manager

Scientists Identify New Antibody for COVID-19 and Variants